Allergan Denies Delaying Restasis Generic In Bid To Stop MDL
Allergan Inc. asked a New York federal court to throw out multidistrict litigation over its alleged effort to delay the launch of a generic version of Restasis, the company's dry-eye medication,...To view the full article, register now.
Already a subscriber? Click here to view full article